The role of stereotactic ablative radiotherapy in oncological and non-oncological clinical settings: Highlights from the 7th Meeting of AIRO - Young Members Working Group (AIRO Giovani)

Pierfrancesco Franco, Berardino De Bari, Patrizia Ciammella, Alba Fiorentino, Silvia Chiesa, Dante Amelio, Valentina Pinzi, Pierluigi Bonomo, Stefano Vagge, Michele Fiore, Tiziana Comito, Agnese Cecconi, Gianluca Mortellaro, Alessio Bruni, Marco Trovo, Andrea Riccardo Filippi, Daniela Greto, Filippo Alongi

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Stereotactic ablative radiotherapy is a modern cancer treatment strategy able to deliver highly focused radiation in one or a few fractions with a radical intent in several clinical settings. Young radiation oncologists need a constant and tailored update in this context to improve patient care in daily clinical practice. A recent meeting of AIRO Giovani (AIRO - Young Members Working Group) was specifically addressed to this topic, presenting state-of-the-art knowledge, based on the latest evidence in this field. Highlights of the congress are summarized and presented in this report, including thorough contributions of the speakers dealing with the role of stereotactic ablative radiotherapy in both oncological and non-oncological diseases, divided according to anatomical and clinical scenarios: intra-cranial settings (brain malignant primary tumors, metastases, benign tumors and functional disorders) and extra-cranial indications (lung primary tumors and metastases, thoracic re-irradiation, liver, lymph node and bone metastases, prostate cancer). With literature data discussed during the congress as a background, stereotactic ablative radiotherapy has proved to be a consolidated treatment approach in specific oncological and non-oncological scenarios, as well as a promising option in other clinical settings, requiring a further prospective validation in the near future. We herein present an updated overview of stereotactic ablative radiotherapy use in the clinic.

Original languageEnglish
Pages (from-to)e214-e229
JournalTumori
Volume100
Issue number6
DOIs
Publication statusPublished - Nov 1 2014

Fingerprint

Radiotherapy
Neoplasm Metastasis
Neoplasms
Brain Neoplasms
Prostatic Neoplasms
Patient Care
Thorax
Lymph Nodes
Radiation
Bone and Bones
Lung
Liver
Therapeutics

Keywords

  • Hypofractionation
  • Image-guide radiotherapy
  • Intensity-modulated radiotherapy
  • Radiosurgery
  • Stereotactic ablative radiotherapy
  • Stereotactic body radiotherapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

The role of stereotactic ablative radiotherapy in oncological and non-oncological clinical settings : Highlights from the 7th Meeting of AIRO - Young Members Working Group (AIRO Giovani). / Franco, Pierfrancesco; De Bari, Berardino; Ciammella, Patrizia; Fiorentino, Alba; Chiesa, Silvia; Amelio, Dante; Pinzi, Valentina; Bonomo, Pierluigi; Vagge, Stefano; Fiore, Michele; Comito, Tiziana; Cecconi, Agnese; Mortellaro, Gianluca; Bruni, Alessio; Trovo, Marco; Filippi, Andrea Riccardo; Greto, Daniela; Alongi, Filippo.

In: Tumori, Vol. 100, No. 6, 01.11.2014, p. e214-e229.

Research output: Contribution to journalArticle

Franco, P, De Bari, B, Ciammella, P, Fiorentino, A, Chiesa, S, Amelio, D, Pinzi, V, Bonomo, P, Vagge, S, Fiore, M, Comito, T, Cecconi, A, Mortellaro, G, Bruni, A, Trovo, M, Filippi, AR, Greto, D & Alongi, F 2014, 'The role of stereotactic ablative radiotherapy in oncological and non-oncological clinical settings: Highlights from the 7th Meeting of AIRO - Young Members Working Group (AIRO Giovani)', Tumori, vol. 100, no. 6, pp. e214-e229. https://doi.org/10.1700/1778.19280
Franco, Pierfrancesco ; De Bari, Berardino ; Ciammella, Patrizia ; Fiorentino, Alba ; Chiesa, Silvia ; Amelio, Dante ; Pinzi, Valentina ; Bonomo, Pierluigi ; Vagge, Stefano ; Fiore, Michele ; Comito, Tiziana ; Cecconi, Agnese ; Mortellaro, Gianluca ; Bruni, Alessio ; Trovo, Marco ; Filippi, Andrea Riccardo ; Greto, Daniela ; Alongi, Filippo. / The role of stereotactic ablative radiotherapy in oncological and non-oncological clinical settings : Highlights from the 7th Meeting of AIRO - Young Members Working Group (AIRO Giovani). In: Tumori. 2014 ; Vol. 100, No. 6. pp. e214-e229.
@article{6e7d3acd400e48c6bec1f59ce540305f,
title = "The role of stereotactic ablative radiotherapy in oncological and non-oncological clinical settings: Highlights from the 7th Meeting of AIRO - Young Members Working Group (AIRO Giovani)",
abstract = "Stereotactic ablative radiotherapy is a modern cancer treatment strategy able to deliver highly focused radiation in one or a few fractions with a radical intent in several clinical settings. Young radiation oncologists need a constant and tailored update in this context to improve patient care in daily clinical practice. A recent meeting of AIRO Giovani (AIRO - Young Members Working Group) was specifically addressed to this topic, presenting state-of-the-art knowledge, based on the latest evidence in this field. Highlights of the congress are summarized and presented in this report, including thorough contributions of the speakers dealing with the role of stereotactic ablative radiotherapy in both oncological and non-oncological diseases, divided according to anatomical and clinical scenarios: intra-cranial settings (brain malignant primary tumors, metastases, benign tumors and functional disorders) and extra-cranial indications (lung primary tumors and metastases, thoracic re-irradiation, liver, lymph node and bone metastases, prostate cancer). With literature data discussed during the congress as a background, stereotactic ablative radiotherapy has proved to be a consolidated treatment approach in specific oncological and non-oncological scenarios, as well as a promising option in other clinical settings, requiring a further prospective validation in the near future. We herein present an updated overview of stereotactic ablative radiotherapy use in the clinic.",
keywords = "Hypofractionation, Image-guide radiotherapy, Intensity-modulated radiotherapy, Radiosurgery, Stereotactic ablative radiotherapy, Stereotactic body radiotherapy",
author = "Pierfrancesco Franco and {De Bari}, Berardino and Patrizia Ciammella and Alba Fiorentino and Silvia Chiesa and Dante Amelio and Valentina Pinzi and Pierluigi Bonomo and Stefano Vagge and Michele Fiore and Tiziana Comito and Agnese Cecconi and Gianluca Mortellaro and Alessio Bruni and Marco Trovo and Filippi, {Andrea Riccardo} and Daniela Greto and Filippo Alongi",
year = "2014",
month = "11",
day = "1",
doi = "10.1700/1778.19280",
language = "English",
volume = "100",
pages = "e214--e229",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "6",

}

TY - JOUR

T1 - The role of stereotactic ablative radiotherapy in oncological and non-oncological clinical settings

T2 - Highlights from the 7th Meeting of AIRO - Young Members Working Group (AIRO Giovani)

AU - Franco, Pierfrancesco

AU - De Bari, Berardino

AU - Ciammella, Patrizia

AU - Fiorentino, Alba

AU - Chiesa, Silvia

AU - Amelio, Dante

AU - Pinzi, Valentina

AU - Bonomo, Pierluigi

AU - Vagge, Stefano

AU - Fiore, Michele

AU - Comito, Tiziana

AU - Cecconi, Agnese

AU - Mortellaro, Gianluca

AU - Bruni, Alessio

AU - Trovo, Marco

AU - Filippi, Andrea Riccardo

AU - Greto, Daniela

AU - Alongi, Filippo

PY - 2014/11/1

Y1 - 2014/11/1

N2 - Stereotactic ablative radiotherapy is a modern cancer treatment strategy able to deliver highly focused radiation in one or a few fractions with a radical intent in several clinical settings. Young radiation oncologists need a constant and tailored update in this context to improve patient care in daily clinical practice. A recent meeting of AIRO Giovani (AIRO - Young Members Working Group) was specifically addressed to this topic, presenting state-of-the-art knowledge, based on the latest evidence in this field. Highlights of the congress are summarized and presented in this report, including thorough contributions of the speakers dealing with the role of stereotactic ablative radiotherapy in both oncological and non-oncological diseases, divided according to anatomical and clinical scenarios: intra-cranial settings (brain malignant primary tumors, metastases, benign tumors and functional disorders) and extra-cranial indications (lung primary tumors and metastases, thoracic re-irradiation, liver, lymph node and bone metastases, prostate cancer). With literature data discussed during the congress as a background, stereotactic ablative radiotherapy has proved to be a consolidated treatment approach in specific oncological and non-oncological scenarios, as well as a promising option in other clinical settings, requiring a further prospective validation in the near future. We herein present an updated overview of stereotactic ablative radiotherapy use in the clinic.

AB - Stereotactic ablative radiotherapy is a modern cancer treatment strategy able to deliver highly focused radiation in one or a few fractions with a radical intent in several clinical settings. Young radiation oncologists need a constant and tailored update in this context to improve patient care in daily clinical practice. A recent meeting of AIRO Giovani (AIRO - Young Members Working Group) was specifically addressed to this topic, presenting state-of-the-art knowledge, based on the latest evidence in this field. Highlights of the congress are summarized and presented in this report, including thorough contributions of the speakers dealing with the role of stereotactic ablative radiotherapy in both oncological and non-oncological diseases, divided according to anatomical and clinical scenarios: intra-cranial settings (brain malignant primary tumors, metastases, benign tumors and functional disorders) and extra-cranial indications (lung primary tumors and metastases, thoracic re-irradiation, liver, lymph node and bone metastases, prostate cancer). With literature data discussed during the congress as a background, stereotactic ablative radiotherapy has proved to be a consolidated treatment approach in specific oncological and non-oncological scenarios, as well as a promising option in other clinical settings, requiring a further prospective validation in the near future. We herein present an updated overview of stereotactic ablative radiotherapy use in the clinic.

KW - Hypofractionation

KW - Image-guide radiotherapy

KW - Intensity-modulated radiotherapy

KW - Radiosurgery

KW - Stereotactic ablative radiotherapy

KW - Stereotactic body radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=84923308841&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923308841&partnerID=8YFLogxK

U2 - 10.1700/1778.19280

DO - 10.1700/1778.19280

M3 - Article

C2 - 25688503

AN - SCOPUS:84923308841

VL - 100

SP - e214-e229

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 6

ER -